News
PMD
2.330
+0.43%
0.010
Weekly Report: what happened at PMD last week (0909-0913)?
Weekly Report · 2d ago
Weekly Report: what happened at PMD last week (0902-0906)?
Weekly Report · 09/09 09:31
Weekly Report: what happened at PMD last week (0826-0830)?
Weekly Report · 09/02 09:33
Weekly Report: what happened at PMD last week (0819-0823)?
Weekly Report · 08/26 09:32
Weekly Report: what happened at PMD last week (0812-0816)?
Weekly Report · 08/19 09:29
Psychemedics GAAP EPS of -$0.14, revenue of $4.7M
Seeking Alpha · 08/14 13:17
PMD Stock Earnings: Psychemedics Reported Results for Q2 2024
Investorplace · 08/14 02:55
Based on the provided financial report articles, the title of the article is likely: "10-Q Quarterly Report (Q2 2024)
Press release · 08/14 01:04
Cannabis Stock Movers For August 13, 2024
Benzinga · 08/13 20:30
*Psychemedics 2Q Loss $0.8M Vs. Loss $0.7M >PMD
Dow Jones · 08/13 20:20
*Psychemedics 2Q Rev $4.7M Vs. $5.5M >PMD
Dow Jones · 08/13 20:19
Psychemedics Corp: [Amend]General statement of acquisition of beneficial ownership
Press release · 08/13 14:11
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Investorplace · 08/13 11:34
Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Benzinga · 08/13 10:35
Cannabis Stock Gainers And Losers From August 12, 2024
Benzinga · 08/12 20:30
PSYCHEMEDICS CORP - PROPOSED REVERSE STOCK SPLIT RATIO BETWEEN 1-FOR-4,000 AND 1-FOR-6,000
Reuters · 08/12 20:12
PSYCHEMEDICS CORPORATION’S BOARD OF DIRECTORS APPROVES PLAN TO TERMINATE REGISTRATION OF ITS COMMON STOCK
Reuters · 08/12 20:12
Press Release: Psychemedics Corporation's Board -2-
Dow Jones · 08/12 20:12
Press Release: Psychemedics Corporation's Board of Directors Approves Plan to Terminate Registration of Its Common Stock
Dow Jones · 08/12 20:12
Weekly Report: what happened at PMD last week (0805-0809)?
Weekly Report · 08/12 09:30
More
Webull provides a variety of real-time PMD stock news. You can receive the latest news about Psychemedics Corp through multiple platforms. This information may help you make smarter investment decisions.
About PMD
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.